Julie D Klapstein
CIK 1518668 · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.27M
Companies
8
Total Filings
46
Lifetime Open-Market Net
$36.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OMDA | Director | 21,965 | $23.67 | $519.9K | $0 | 4 | 2026-07-07 |
| Claritev Corp (MPLN) Delisted | Director | 24,611 | $23.15 | $569.7K | $0 | 3 | 2026-05-01 |
| AMEDISYS INC (AMED) Delisted | Director | 0 | $100.99 | $0 | -$85.7K | 14 | 2025-08-14 |
| NEXTGEN HEALTHCARE, INC. (NXGN) Delisted | Director | 70,104 | $23.94 | $1.68M | $0 | 5 | 2023-08-23 |
| Oak Street Health, Inc. (OSH) Delisted | Director | 0 | $39.00 | $0 | $50.0K | 6 | 2023-05-02 |
| Claritev Corp (MPLN.WS) Delisted | Director | 158,758 | $0.00 | $476 | $72.0K | 5 | 2023-04-28 |
| Annie's, Inc. (BNNY) Delisted | Director | 3,828 | — | — | $0 | 3 | 2014-09-11 |
| SR | Director | 9,190 | $81.97 | $753.3K | $0 | 2 | 2013-11-04 |
Recent Filings · Page 4 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-03 | AMEDISYS INC (AMED) Delisted | Sell (S) | −250 | -$44.7K | EDGAR |
| 2020-01-06 | AMEDISYS INC (AMED) Delisted | Sell (S) | −250 | -$41.1K | EDGAR |
| 2019-08-16 | NEXTGEN HEALTHCARE, INC. (NXGN) Delisted | Grant (A) | +11,419 | $0 | EDGAR |
| 2019-06-11 | AMEDISYS INC (AMED) Delisted | Grant (A) | +1,297 | $0 | EDGAR |
| 2018-08-15 | — | Grant (A) | +6,631 | $0 | |
| 2018-06-08 | AMEDISYS INC (AMED) Delisted | Grant (A) | +1,863 | $0 | EDGAR |
| 2017-08-23 | — | Grant (A) | +9,189 | $0 | |
| 2017-06-12 | AMEDISYS INC (AMED) Delisted | Grant (A) | +2,394 | $0 | EDGAR |
| 2016-07-05 | AMEDISYS INC (AMED) Delisted | Grant (A) | +2,477 | $0 | EDGAR |
| 2016-05-03 | AMEDISYS INC (AMED) Delisted | Grant (A) | +462 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.